• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Interview Intersection: Expert Interviews From April 2024


Dermatology Times is recapping our top expert interviews from the month of April.

Mona Shahriari, MD, FAAD: 'The Days of Paternalistic Medicine Are Gone'

Shahriari shares pearls and considerations from her sessions at the recent Diversity in Dermatology conference.

Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand

Shah discusses the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.

New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging

In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.

Increased Levels of B-Type Natriuretic Peptide May be Associated With Various Types of Chronic Itch

Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.

Topics and Pearls

  • Disease states such as chronic itch, atopic dermatitis, plaque psoriasis, and skin cancer
  • Avoiding hurdles in insurance and patients of special populations to achieve equitable care
  • Anti-aging research
  • Launching a skin care brand
  • Pearls for integrative medicine, gut health and the microbiome, and melanoma 'overdiagnosis'

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.

Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks

Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.

Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting

Miranti presented tips on handling denial hurdles and how to ensure patients receive access to the treatments they need.

Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Noor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board.

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.

Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.

Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More

Hasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.

Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients

Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.

Clinician and Patient Perspective: Tapinarof Cream for Plaque Psoriasis

Mona Shahriari, MD, and a plaque psoriasis patient provide insights into the mechanism of action and benefits of tapinarof cream 1% as a nonsteroidal topical.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.